Migdal Insurance & Financial Holdings’s C4 Therapeutics CCCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-605
Closed -$20K 614
2021
Q4
$20K Sell
605
-589
-49% -$19.5K ﹤0.01% 558
2021
Q3
$53K Buy
+1,194
New +$53K ﹤0.01% 438